RxDoctor Payments Data

Paul Friedlander, MD

Otolaryngology · New Orleans, LANPI 1225050735

Payments from drug & device makers

What this record shows

This record is dominated by education: $3,500 of the $5,738 with a category attached, or 61.0%. Intuitive Surgical accounts for 86.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $4,952 and has fallen 99.5% since, to $26 in 2025.

$5,738in general payments, 2019–2025

Across 32 payments — averaging $179.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • Olympus America Inc.$168
  • Aerin Medical Inc.$125
  • Medtronic$120
  • Merck$112
  • Intersect ENT, Inc.$99
  • plus $171 from 6 others
$106in research payments, 2019–2025

Across 1 payment — averaging $105.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$106

What the payments were for

  • Travel & lodging$1,43125%
  • Food & beverage$80714%
  • Education$3,50061%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,738 in reported general payments places this provider in the 85th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$12,388
Medicare patients
48
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium11$99

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →